![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Phrase 3, French Multicenter, Open-Label Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve HCV GT1b-Infected Patients with non-severe Fibrosis: STREAGER study
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
![1024171](../images/102417/102417-6/1024171.gif)
![1024172](../images/102417/102417-6/1024172.gif)
![1024173](../images/102417/102417-6/1024173.gif)
![1024174](../images/102417/102417-6/1024174.gif)
![1024175](../images/102417/102417-6/1024175.gif)
![1024176](../images/102417/102417-6/1024176.gif)
![1024177](../images/102417/102417-6/1024177.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|